SMBPX vs. SHPAX
Compare and contrast key facts about Saratoga Municipal Bond Portfolio (SMBPX) and Saratoga Health & Biotechnology Fund (SHPAX).
SMBPX is managed by Saratoga. It was launched on Sep 1, 1994. SHPAX is managed by Saratoga. It was launched on Jul 14, 1999.
Performance
SMBPX vs. SHPAX - Performance Comparison
Loading graphics...
SMBPX vs. SHPAX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SMBPX Saratoga Municipal Bond Portfolio | 0.00% | 2.92% | -0.11% | 1.84% | -2.57% | -1.39% | 0.77% | 1.00% | -2.38% | 2.12% |
SHPAX Saratoga Health & Biotechnology Fund | -1.13% | 17.43% | 0.26% | -0.36% | 1.93% | 16.71% | 3.52% | 27.67% | -5.30% | 11.78% |
Returns By Period
Over the past 10 years, SMBPX has underperformed SHPAX with an annualized return of -0.09%, while SHPAX has yielded a comparatively higher 6.84% annualized return.
SMBPX
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- 0.00%
- 6M
- 0.73%
- 1Y
- 3.27%
- 3Y*
- 1.35%
- 5Y*
- 0.13%
- 10Y*
- -0.09%
SHPAX
- 1D
- 0.96%
- 1M
- -6.99%
- YTD
- -1.13%
- 6M
- 10.24%
- 1Y
- 12.17%
- 3Y*
- 6.93%
- 5Y*
- 5.73%
- 10Y*
- 6.84%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
SMBPX vs. SHPAX - Expense Ratio Comparison
SMBPX has a 3.16% expense ratio, which is higher than SHPAX's 2.90% expense ratio.
Return for Risk
SMBPX vs. SHPAX — Risk / Return Rank
SMBPX
SHPAX
SMBPX vs. SHPAX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Saratoga Municipal Bond Portfolio (SMBPX) and Saratoga Health & Biotechnology Fund (SHPAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SMBPX | SHPAX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.11 | 0.78 | +0.33 |
Sortino ratioReturn per unit of downside risk | 1.46 | 1.18 | +0.29 |
Omega ratioGain probability vs. loss probability | 1.37 | 1.15 | +0.22 |
Calmar ratioReturn relative to maximum drawdown | 0.59 | 1.56 | -0.97 |
Martin ratioReturn relative to average drawdown | 2.15 | 4.30 | -2.15 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| SMBPX | SHPAX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.11 | 0.78 | +0.33 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.06 | 0.41 | -0.34 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.05 | 0.41 | -0.46 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.88 | 0.30 | +0.58 |
Correlation
The correlation between SMBPX and SHPAX is -0.03. This indicates that the assets' prices tend to move in opposite directions. Negative correlation can be particularly beneficial for diversification and risk management, as one asset may offset the losses of the other during market fluctuations.
Dividends
SMBPX vs. SHPAX - Dividend Comparison
SMBPX's dividend yield for the trailing twelve months is around 2.69%, less than SHPAX's 3.70% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SMBPX Saratoga Municipal Bond Portfolio | 2.69% | 2.69% | 1.16% | 0.00% | 0.00% | 0.04% | 0.10% | 0.10% | 0.36% | 0.23% | 4.23% | 1.50% |
SHPAX Saratoga Health & Biotechnology Fund | 3.70% | 3.66% | 1.35% | 5.38% | 6.34% | 3.76% | 13.82% | 13.24% | 22.00% | 17.98% | 12.52% | 10.70% |
Drawdowns
SMBPX vs. SHPAX - Drawdown Comparison
The maximum SMBPX drawdown since its inception was -9.99%, smaller than the maximum SHPAX drawdown of -69.50%. Use the drawdown chart below to compare losses from any high point for SMBPX and SHPAX.
Loading graphics...
Drawdown Indicators
| SMBPX | SHPAX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -9.99% | -69.50% | +59.51% |
Max Drawdown (1Y)Largest decline over 1 year | -3.63% | -7.87% | +4.24% |
Max Drawdown (5Y)Largest decline over 5 years | -6.72% | -16.32% | +9.60% |
Max Drawdown (10Y)Largest decline over 10 years | -9.99% | -28.05% | +18.06% |
Current DrawdownCurrent decline from peak | -2.99% | -6.99% | +4.00% |
Average DrawdownAverage peak-to-trough decline | -2.47% | -28.07% | +25.60% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 1.03% | 2.86% | -1.83% |
Volatility
SMBPX vs. SHPAX - Volatility Comparison
The current volatility for Saratoga Municipal Bond Portfolio (SMBPX) is 0.00%, while Saratoga Health & Biotechnology Fund (SHPAX) has a volatility of 4.62%. This indicates that SMBPX experiences smaller price fluctuations and is considered to be less risky than SHPAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| SMBPX | SHPAX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 0.00% | 4.62% | -4.62% |
Volatility (6M)Calculated over the trailing 6-month period | 0.86% | 9.76% | -8.90% |
Volatility (1Y)Calculated over the trailing 1-year period | 3.38% | 16.57% | -13.19% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 2.20% | 14.19% | -11.99% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 1.97% | 16.57% | -14.60% |